Al-Hidaya brings Medizone's AsepticSure systems into the Kingdom of Saudi Arabia to reduce MERS-coronavirus

NewsGuard 100/100 Score

Medizone International, Inc. (The Company) (OTCBB: MZEI, OTCQB: MZEI), manufacturers of the AsepticSure® Hospital Disinfection System, are pleased to announce the recent sale and delivery of the initial two AsepticSure systems to Al-Hidaya International Medical Services Company headquartered in Jeddah, the Kingdom of Saudi Arabia. ( https://alhidaya.com.sa ).

Al-Hidaya is under the leadership of Sheikh Saleh Salem M. Bahwini. Sheikh Bahwini has committed to helping rid the Kingdom of the MERS-coronavirus.

Al-Hidaya has sponsored a trip to the Kingdom for Medizone's President and Director of Medical Affairs, Dr. Michael E. Shannon M.A.,M.Sc.,M.D. Dr. Shannon and his support team arrived in Jeddah the end of last week. Dr. Shannon and the team had been graciously invited to the Kingdom by the Minister of Health's Office.

With the support of Dr. Shannon, Al-Hidaya is working with the regulatory agencies to satisfy any remaining requirements to bring AsepticSure into the Kingdom and allow us to contribute to reducing the incidence of MERS-coronavirus in Saudi hospitals with the use of AsepticSure. Dr. Shannon and his team will remain in Saudi Arabia until September 14th.

Prior to this trip, Al-Hidaya International Medical Services Company had applied for Exclusive Distribution Rights for AsepticSure in the Kingdom. Medizone had responded with a Letter of Intent to Grant such rights, subject to the completion of a formal contractual agreement. Given Al-Hidaya's demonstrated commitment and effort to date, Medizone believes the final contract details will be agreed to following current activities.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does diabetes increase the risk of long COVID?